{"entity":{"id":"anthony-goncalves","kind":"person","name":"Anthony Gonçalves","aka":[],"tldr":"Anthony Gonçalves is a medical oncologist leading breast and ovarian cancer research at Institut Paoli-Calmettes.","summary":"Anthony Gonçalves is Head of Medical Oncology at Institut Paoli-Calmettes in Marseille, part of the UNICANCER network of French cancer centres. His specialisms are breast cancer, ovarian cancer and translational research, and he leads UNICANCER breast and gynaecological trials alongside translational genomics programmes. His papers include the UCBG 12-1 phase II trial of abiraterone acetate plus prednisone in androgen receptor-positive triple-negative breast cancer, the New England Journal of Medicine report of talazoparib in advanced breast cancer with a germline BRCA mutation, and the BAYPAN phase III trial of gemcitabine with sorafenib in advanced pancreatic cancer. His publications are listed on PubMed.","asOf":"2026-09-08","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Goncalves%20A%5BAuthor%5D%20breast%20cancer"}],"tags":[],"related":[],"cancers":["breast-hr-positive","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["unicancer"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Head of Medical Oncology, Institut Paoli-Calmettes, Marseille","institutionId":"unicancer","specialisms":["Breast cancer","Ovarian cancer","Translational research"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Goncalves%20A%5BAuthor%5D%20breast%20cancer"}],"papers":[{"title":"A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)","journal":"Annals of Oncology","year":2016,"doi":"10.1093/annonc/mdw067"},{"title":"Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation","journal":"New England Journal of Medicine","year":2018,"doi":"10.1056/nejmoa1802905"},{"title":"BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer","journal":"Annals of Oncology","year":2012,"doi":"10.1093/annonc/mds135"}]},"route":"/people/anthony-goncalves/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"company":[{"id":"unicancer","kind":"company","name":"UNICANCER","route":"/companies/unicancer/"}],"institution":[{"id":"institut-paoli-calmettes","kind":"institution","name":"Institut Paoli-Calmettes","route":"/institutions/institut-paoli-calmettes/"}]}}